Susquehanna International Group, LLP Nemaura Medical Inc. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.32 - $1.14 $6,473 - $23,062	20,230 New	20,230 $6,000
Q4 2022 Feb 14, 2023	SELL	$1.72 - $3.13 $9,692 - $17,637	-5,635 Reduced 20.66%	21,636 $37,000
Q3 2022 Nov 14, 2022	SELL	$1.52 - $2.57 $24,897 - $42,096	-16,380 Reduced 37.52%	27,271 $57,000
Q2 2022 Aug 15, 2022	SELL	$2.53 - $4.42 $47,652 - $83,250	-18,835 Reduced 30.14%	43,651 $113,000
Q1 2022 May 16, 2022	BUY	$3.78 - $4.66 $19,603 - $24,166	5,186 Added 9.05%	62,486 $273,000
Q4 2021 Feb 14, 2022	BUY	$4.12 - $6.35 $143,396 - $221,011	34,805 Added 154.72%	57,300 $261,000
Q3 2021 Nov 15, 2021	SELL	$5.76 - $9.95 $48,608 - $83,968	-8,439 Reduced 27.28%	22,495 $135,000
Q1 2021 May 17, 2021	BUY	$3.79 - $9.78 $117,239 - $302,534	30,934 New	30,934 $236,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.